Novel quinoline derivatives containing substituted oxadiazole as an anticancer agent

IN604936BActive Publication Date: 2026-10-05ATMIYA UNIV +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202321086930
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-12-19
Publication Date
2026-10-05
Patent Text Reader

Abstract

ABSTRACT Novel quinoline derivatives containing substituted oxadiazole as an anticancer agent The present invention relates to the synthesis of novel quinoline derivatives containing substituted oxadiazole and evaluation of their anti-cancer activities. The quinolone based 1,2,4-oxadiazol-5(4H)-one ring (6a to 6p) derivatives and 1,2,4-oxadiazole-5(4H)-thione ring (7a to 7p) derivatives are synthesized using the formula (I). The anti-cancer activities of synthesized hybrid molecules show promising anticancer activity on Central Nervous System Cancer Cell Line: SNB-75, Melanoma Cell Line: MDA-MB 435 & SK-MEL 5, and in Breast Cancer Cell Line: T- 47D & MDA-MB-468 cell-lines. (I)
Need to check novelty before this filing date? Find Prior Art